Your browser doesn't support javascript.
loading
Treatment of refractory obsessive-compulsive disorder with nutraceuticals (TRON): a 20-week, open label pilot study.
Sarris, Jerome; Byrne, Gerard J; Oliver, Georgina; Cribb, Lachlan; Blair-West, Scott; Castle, David; Dean, Olivia M; Camfield, David A; Brakoulias, Vlasios; Bousman, Chad; Dowling, Nathan; Ee, Carolyn; Murphy, Jenifer; Menon, Ranjit; Berk, Michael; Chamoli, Suneel; Boschen, Mark; Ng, Chee H.
Afiliación
  • Sarris J; NICM Health Research Institute, Western Sydney University, Westmead, New South Wales, Australia.
  • Byrne GJ; The Melbourne Clinic, Department of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia.
  • Oliver G; University of Queensland Centre for Clinical Research, Royal Brisbane & Women's Hospital, Brisbane, Queensland, Australia.
  • Cribb L; Mental Health Service, Royal Brisbane & Women's Hospital, Brisbane, Queensland, Australia.
  • Blair-West S; The Melbourne Clinic, Department of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia.
  • Castle D; The Melbourne Clinic, Department of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia.
  • Dean OM; The Melbourne Clinic, Department of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia.
  • Camfield DA; Centre for Complex Interventions, Department of Psychiatry, University of Toronto.
  • Brakoulias V; Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Barwon Health, Deakin University, Geelong, Victoria, Australia.
  • Bousman C; Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Barwon Health, Deakin University, Geelong, Victoria, Australia.
  • Dowling N; Western Sydney Local Health District Mental Health Service, Sydney, New South Wales, Australia.
  • Ee C; School of Medicine, Blacktown Hospital, Translational Health Research Institute (THRI), Clinical and Health Psychology Research Initiative (CaHPRI), Western Sydney University, Sydney, New South Wales, Australia.
  • Murphy J; Department of Medical Genetics, University of Calgary, Calgary, Alberta, Canada.
  • Menon R; Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada.
  • Berk M; Department of Physiology & Pharmacology, University of Calgary, Calgary, Alberta, Canada.
  • Chamoli S; The Melbourne Clinic, Department of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia.
  • Boschen M; NICM Health Research Institute, Western Sydney University, Westmead, New South Wales, Australia.
  • Ng CH; The Melbourne Clinic, Department of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia.
CNS Spectr ; 27(5): 588-597, 2022 10.
Article en En | MEDLINE | ID: mdl-34165060
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Selenio / Trastorno Obsesivo Compulsivo Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Revista: CNS Spectr Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Selenio / Trastorno Obsesivo Compulsivo Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Revista: CNS Spectr Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Australia